Articles related to ATTENTION-DEFICIT HYPERACTIVITY DISORDER (ADHD)

The recent recall of Zenzedi 30 mg tablets due to contamination stresses the importance of meticulous medication management and awareness of the broader challenges in ADHD treatment availability and safety.

Recent findings highlight a significant overlap between ADHD and ASD, particularly in symptomatology and diagnostic challenges. Understanding these nuances is crucial for accurate patient assessment and treatment.

Emerging evidence suggests a nuanced relationship between diet and ADHD, highlighting the potential of micronutrients and specific dietary patterns in symptom management. Personalized nutrition strategies are gaining traction as a complement to traditional ADHD treatments.

A recent study reveals a significant association between prolonged ADHD medication use and cardiovascular risk, emphasizing the need for vigilant cardiovascular monitoring in these patients.

The study suggests that although unlicensed doses may lead to additional symptom reduction, the gains are small and come with an increased risk of adverse events.

Explore the potential of solriamfetol as an effective and well-tolerated treatment for adult ADHD in this intriguing pilot study.